Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
03/03/2011 | US20110053245 Isomerases, nucleic acids encoding them and methods for making and using them |
03/03/2011 | US20110053236 Ethanol production |
03/03/2011 | US20110053225 Multifunctional tags |
03/03/2011 | US20110053221 Recombinant production of authentic human proteins using human cell expression systems |
03/03/2011 | US20110053219 Method for the Targeted Integration of Multiple Copies of a Gene of Interest in a Yarrowia Strain |
03/03/2011 | US20110053218 Multiple promoter platform for protein production |
03/03/2011 | US20110053217 Polynucleotides encoding signal peptide-containing molecules |
03/03/2011 | US20110053216 Modified Cyanobacteria |
03/03/2011 | US20110053213 Polypeptides Having Ferulic Acid Esterase Activity and Polynucleotides Encoding Same |
03/03/2011 | US20110053195 Catalytically inactive proteins and method for recovery of enzymes from plant-derived materials |
03/03/2011 | US20110053189 Type IV secretion system proteins in sero-detection of Anaplasma phagocytophium |
03/03/2011 | US20110053166 Stem cell expression cassettes |
03/03/2011 | US20110053160 Hcv ns3/4a replicon shuttle vectors |
03/03/2011 | US20110053147 Heat-resistant dna ligase with high reactivity |
03/03/2011 | US20110053138 Universal multi-variant detection system |
03/03/2011 | US20110053137 Methods of modulating cold sensory perception |
03/03/2011 | US20110052758 Heat-stable asparaginase for reducing acrylamide in food stuffs or stimulants |
03/03/2011 | US20110052677 Modulation of srpx2-mediated angiogenesis |
03/03/2011 | US20110052670 Identification of a pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
03/03/2011 | US20110052669 Methods for modulating de novo hepatic lipogenesis by modulating xbp-1 activity |
03/03/2011 | US20110052640 Hypoallergenic hybrid proteins of major group 1 and 2 mite allergens for use in the treatment of allergies |
03/03/2011 | US20110052637 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as vaccines |
03/03/2011 | US20110052634 Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof |
03/03/2011 | US20110052632 Hiv polynucleotides and polypeptides derived from botswana mj4 |
03/03/2011 | US20110052628 Recombinant Double-Stranded RNA Phage, and Use of the Same |
03/03/2011 | US20110052626 Leporipoxvirus-derived vaccine vectors |
03/03/2011 | US20110052621 Pcsk9 vaccine |
03/03/2011 | US20110052617 Aav scleroprotein, production and use thereof |
03/03/2011 | US20110052615 Tumour-specific animal proteins |
03/03/2011 | US20110052608 Novel antibodies against prion protein and uses thereof |
03/03/2011 | US20110052607 Methods of diagnosing myelodysplastic syndrome (mds) or leukemia using nucleic acids or fragments encoding flt3 kinase |
03/03/2011 | US20110052604 Human Anti-OPGL Neutralizing Antibodies as Selective OPGL Pathway Inhibitors |
03/03/2011 | US20110052601 Compositions comprising anti-icam-1 antibodies |
03/03/2011 | US20110052597 Anti-IL-13R Alpha1 Antibodies and Their Uses Thereof |
03/03/2011 | US20110052596 Antibodies to il-17a |
03/03/2011 | US20110052595 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
03/03/2011 | US20110052593 Breast cancer associated antigen |
03/03/2011 | US20110052592 Compositions and Methods for Use for Antibodies Against Sclerostin |
03/03/2011 | US20110052591 Variants of Thyroid Stimulating Hormone Beta |
03/03/2011 | US20110052587 Peptide or protein comprising a c'-d loop of the cd28 receptor family |
03/03/2011 | US20110052585 Compositions and methods for inhibiting interleukin pathways |
03/03/2011 | US20110052584 Method of enhancement of cytotoxicity in antibody mediated immune responses |
03/03/2011 | US20110052582 Humanized Anti-CDCP1 Antibodies |
03/03/2011 | US20110052577 Antibodies |
03/03/2011 | US20110052571 Method for treating idiopathic thrombocytopenic purpura using monoclonal antibodies |
03/03/2011 | US20110052565 Non-aggregating human vh domains |
03/03/2011 | US20110052558 Materials and methods for prevention and treatment of rna viral diseases |
03/03/2011 | US20110052499 Baboon homolog of human cd147 |
03/03/2011 | US20110052494 H-antigen binding polypeptides and methods of use |
03/03/2011 | US20110052493 Use of polypeptides obtained through systematic mutations of single amino acids of human and non-human box-a of hmgb1 to prevent and/or antagonize pathologies induced by hmgb1 |
03/03/2011 | US20110048950 Methods and apparatus for particle introduction and recovery |
03/03/2011 | US20110048437 Tobacco nicotine demethylase genomic clone and uses thereof |
03/03/2011 | DE112009001080T5 Verfahren zum Herstellen von β-Alanylaminosäure oder eines Derivats davon A process for producing β-alanyl-amino acid or a derivative thereof |
03/03/2011 | DE102007004283B4 Magnetresonanz-Kontrastmittel mit eisenbindendem Protein Magnetic resonance contrast agent with eisenbindendem protein |
03/03/2011 | CA2772654A1 Polynucleotides derived from chickpea and uses thereof |
03/03/2011 | CA2772551A1 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
03/03/2011 | CA2772298A1 Methods for creating antibody libraries |
03/03/2011 | CA2772267A1 Regulatory nucleic acid molecules for enhancing seed-specific gene expression in plants promoting enhanced polyunsaturated fatty acid synthesis |
03/03/2011 | CA2772224A1 Complete genome sequence of the methanogen methanobrevibacter ruminantium |
03/03/2011 | CA2772106A1 Fusarium and fusarium mycotoxin biocontrol |
03/03/2011 | CA2772036A1 Targeting pax2 for the treatment of breast cancer |
03/03/2011 | CA2771993A1 Detecting pax2 for the diagnosis of breast cancer |
03/03/2011 | CA2771927A1 Proteins relating to grain shape and leaf shape of rice, coding genes and uses thereof |
03/03/2011 | CA2771755A1 Modified transgene encoding a growth and/or development related protein in plants |
03/03/2011 | CA2771328A1 Cofactors for thrombin activation of factor vii and uses thereof |
03/03/2011 | CA2771253A1 Regulatory nucleic acid molecules for enhancing seed-specific and/or seed-preferential gene expression in plants |
03/03/2011 | CA2771252A1 Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants |
03/03/2011 | CA2771178A1 Compositions and methods to control insect pests |
03/03/2011 | CA2770572A1 Nematode-resistant transgenic plants |
03/03/2011 | CA2769879A1 Polynucleotide derived from novel hepatitis c virus strain and use thereof |
03/03/2011 | CA2769289A1 Development of universal cancer drugs and vaccines |
03/03/2011 | CA2767145A1 Method for selection of barley species based on protein z7 content, and fermented malt beverage |
03/03/2011 | CA2754024A1 Antibody fusion-mediated plant resistance against oomycota |
03/02/2011 | EP2290364A1 Light-controlled electrokinetic assembly of particles near surfaces |
03/02/2011 | EP2290107A1 Kunitz domain library |
03/02/2011 | EP2290106A1 Methods and compositions for generating and amplifying DNA libraries for sensitive detection and analysis of DNA methylation |
03/02/2011 | EP2290105A1 Method for detecting cellular proliferative disorders |
03/02/2011 | EP2290104A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
03/02/2011 | EP2290103A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
03/02/2011 | EP2290101A2 Assay for nucleic acid detection employing nuclease protection fragments |
03/02/2011 | EP2290099A1 Processes for isolating, amplifying and characterizing DNA |
03/02/2011 | EP2290098A1 Preparing crude biological extracts using protease, suitable for preparing cDNA |
03/02/2011 | EP2290096A2 Recombinase polymerase amplification |
03/02/2011 | EP2290095A1 Method and kit for the diagnosis of ulcerative colitis |
03/02/2011 | EP2290092A1 Method for production of l-amino acid |
03/02/2011 | EP2290091A2 Recombinant measles viruses expressing epitopes of antigens of RNA viruses and use of the recombinant viruses for the preparation of vaccine compositions |
03/02/2011 | EP2290090A1 Methods for stable transformation of plants |
03/02/2011 | EP2290089A2 Barley for production of flavor-stable beverage |
03/02/2011 | EP2290088A1 Methods for producing soluble multi-menbrane-spanning proteins |
03/02/2011 | EP2290087A2 Methods for producing soluble multi-membrane-spanning proteins |
03/02/2011 | EP2290086A2 Methods for producing soluble multi-membrane-spanning proteins |
03/02/2011 | EP2290085A2 Method for the in situ production of an emulsifier in a foodstuff |
03/02/2011 | EP2290084A2 Wheat with altered branching enzyme activity and starch and starch containing products derived therefrom |
03/02/2011 | EP2290083A1 Conserved neisserial antigens |
03/02/2011 | EP2290082A1 Streptococcus pyogenes antigens |
03/02/2011 | EP2290081A2 IL-17 homologous polypeptide and therapeutic uses thereof |
03/02/2011 | EP2290080A2 Compositions and methods for diagnosing or treating psoriasis |
03/02/2011 | EP2290079A2 Neurotrophic factors |
03/02/2011 | EP2290078A2 Immunostimulatory nucleic acids |
03/02/2011 | EP2290077A2 Natural IGM antibodies and inhibitors thereof |